Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed through a tissue biopsy with a specific type of anal canal cancer (squamous, basaloid, or cloacogenic carcinoma)
- People whose cancer meets certain size or spread criteria based on medical staging — specifically a tumour larger than 4 cm, or cancer that has spread to nearby lymph nodes (confirm with trial site for exact staging details)
- People aged 18 or older
- People who are well enough to carry out basic daily activities, as measured by a standard health performance scale (confirm with trial site)
- People expected to live longer than 12 months
- People whose blood, liver, and kidney function results fall within acceptable ranges as determined by the trial site's laboratory tests
- People who are able and willing to use effective contraception (such as hormonal methods, barrier methods, or abstinence) during the trial and for 6 months after treatment ends, and who agree to report any pregnancies
- People who are able to understand the trial information and are willing to sign a written consent form
Who may not be able to join:
- People who have had or currently have another invasive cancer (other than certain common skin cancers), unless they have been cancer-free for 2 or more years
- People who have previously received chemotherapy or radiation treatment for anal cancer
- People whose anal cancer has already been completely removed by surgery
- People whose cancer has come back or spread to distant parts of the body
- People who have had a known allergic reaction to the chemotherapy drugs 5-Fluorouracil or mitomycin C
- People who have artificial organ implants, a pacemaker, or other implanted medical devices
- People who have previously had radiation therapy to the pelvic area in a way that would overlap with the radiation fields planned for this trial
- People with serious uncontrolled illness, including HIV with a low immune cell count (CD4 below 200) or significant heart disease
- People who are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lisa Kachnic, MD, Principal Investigator
Phone: 646-317-4244
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to plan and deliver treatment fractions.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.